The effects of RG 7685 and exenatide on insulin secretion and gastric emptying in volunteers

Trial Profile

The effects of RG 7685 and exenatide on insulin secretion and gastric emptying in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Nov 2013

At a glance

  • Drugs RG 7685 (Primary) ; Exenatide
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 19 Nov 2013 New trial record
    • 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top